{
  "id": "Ex017",
  "type": "Example",
  "informationId": {
    "id": "_b3390",
    "type": "CriterionAssessment",
    "criterion": {
      "id": "SEPIO-CG:99027",
      "type": "Criterion",
      "label": "PM1",
      "description": "Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation",
      "defaultStrength": {
        "id": "SEPIO:0000216",
        "type": "EvidenceLineStrength",
        "label": "Pathogenic Moderate"
      },
      "comments": "Suggested that this rule is NOT appropriate for LOF variants.\nAlso, note that when the region of interest is a “well-established functional domain” then it’s not necessary to show through evidence that it is intolerant of benign missense variants.  However, when a mutational hotspot is being defined, then showing it does not have benign missense variants is important."
    },
    "variant": {
      "id": "CAR:CA123651",
      "type": "CanonicalAllele",
      "preferredCtxAllele": {
        "id": "_b128",
        "type": "ContextualAllele",
        "relatedCanonicalAllele": "CanAll026",
        "alleleName": "NM_004333.4(BRAF):c.1789C>G"
      }
    },
    "outcome": {
      "id": "SEPIO:0000223",
      "type": "CriterionEvaluation",
      "label": "Met"
    },
    "evidenceLine": [
      {
        "id": "_b2122",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "_b3142",
            "type": "RegionType",
            "region": {
              "id": "_b3480",
              "type": "SequenceLocation",
              "referenceSequence": {
                "id": "REFSEQ:NM_004333.4",
                "type": "ReferenceSequence",
                "accession": "NM_004333.4"
              },
              "start": 1803,
              "stop": 1921
            },
            "annotation": [
              {
                "id": "SEPIO:0000320",
                "type": "RegionAnnotation",
                "label": "functional region"
              }
            ],
            "description": "This region is exon 15 in the transcript, and codes the serine-threonine-protein kinase catalytic domain."
          },
          {
            "id": "_b3481",
            "type": "RegionAlleles",
            "region": {
              "id": "_b3480",
              "type": "SequenceLocation",
              "referenceSequence": {
                "id": "REFSEQ:NM_004333.4",
                "type": "ReferenceSequence",
                "accession": "NM_004333.4"
              },
              "start": 1803,
              "stop": 1921
            },
            "allele": [
              {
                "id": "_b128",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll026",
                "alleleName": "NM_004333.4(BRAF):c.1789C>G"
              }
            ],
            "outcome": {
              "id": "RO:0002656",
              "type": "RegionAllelesOutcome",
              "label": "overlaps region"
            },
            "description": "This region is exon 15 in the transcript, and codes the serine-threonine-protein kinase catalytic domain."
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent001",
          "type": "Agent",
          "label": "Harry Stevenson"
        },
        "contributionDate": "6/6/16 10:53 AM",
        "contributionRole": {
          "id": "SEPIO:0000154",
          "type": "ContributoryRole",
          "label": "assessor role"
        }
      },
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent002",
          "type": "Agent",
          "label": "Noonan/Rasopathy WG (ClinGen)"
        },
        "contributionDate": "6/6/16 10:53 AM",
        "contributionRole": {
          "id": "SEPIO:0000154",
          "type": "ContributoryRole",
          "label": "assessor role"
        }
      }
    ],
    "description": "Variant is located in exon 15, which the RASopathy group has decided is an established functional domain for BRAF"
  },
  "index": 2,
  "author": "Steven Harrison",
  "description": "Assessed variant: NM_004333.4(BRAF):c.1789C>G (p.Leu597Val)\nRASopathy group decided that exon 15 of BRAF, which encodes the serine-threonine-protein kinase catalytic domain, is an established functional domain for BRAF. Thus, in assessing c.1789C>G, which falls in exon 15, applying PM1 is appropriate",
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
